Osteoporosis.

被引:5
作者
Cimaz R. [1 ]
Biggioggero M. [1 ]
机构
[1] Department of Pediatrics, ICP, Clinica Pediatrica, Via Commenda 9, Milano
关键词
Bone Mineral Density; Osteoporosis; Bone Mass; Juvenile Idiopathic Arthritis; Alendronate;
D O I
10.1007/s11926-996-0005-7
中图分类号
学科分类号
摘要
Bone mass is determined primarily by genetic influences, but exogenous factors may also play a major role. The prevention of osteoporosis can start at childhood. Optimal achievement of peak bone mass during childhood and adolescence is important to minimize future fracture risk. Chronic inflammatory diseases can have a detrimental effect on bone mass through a variety of mechanisms. Different diagnostic methods for detecting osteoporosis (eg, dual x-ray absorptiometry, quantitative computed tomography, ultrasounds) are in use or under investigation. New treatment options are available; among these, the use of bisphosphonates seems to be the more promising approach.
引用
收藏
页码:365 / 370
页数:5
相关论文
共 113 条
[31]  
Polito C(2000)Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis J Rheumatol 27 1073-1081
[32]  
Strano CG(1999)Bisphosphonates: from the laboratory to the clinic and back again Bone 25 97-106
[33]  
Rea L(1996)Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodelling Calcif Tissue Int 58 166-169
[34]  
Rabinovich EC(2000)Intravenous pamidronate in juvenile osteoporosis Arch Dis Child 83 143-145
[35]  
Varamos S(1999)Expanding role of bisphosphonate therapy in children J Pediatr 134 264-267
[36]  
Ansell BM(1992)Epi- and metaphyseal changes in children causes by administration of bisphosphonates Radiology 184 249-254
[37]  
Reeve J(1997)Long-term effects of bisphosphonates on the growing skeleton: studies of young patients with severe osteoporosis Medicine (Baltimore) 76 266-283
[38]  
Warady BD(1998)Cyclic administration of pamidronate in children with severe osteogenesis imperfecta N Engl J Med 339 947-952
[39]  
Lindsley CB(2000)Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children Arthritis Rheum 43 1960-1966
[40]  
Robinson RG(undefined)undefined undefined undefined undefined-undefined